Trial intelligence / Profile preview

Phase II dose-finding study of oral SSS17 capsule for anemia in non-dialysis chronic kidney disease

CTR20222455Phase 2Active

Sponsor
3SBio
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SSS-17 in anemia of chronic kidney disease, sponsored by 3SBio. Started Mar 2023; status: active.

02

Drugs

SSS-17
03

Conditions

anemia of chronic kidney disease

Beyond the preview

Go deeper on CTR20222455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20222455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call